Table 2 Recommended criteria for future SCH and SCH reporting, including age categorisation
Criteria | Definitions |
|---|---|
Year(s) of study completion | Year and month—relevance for seasonality in future analyses |
No. of participants | Overall and age/sex breakdowns |
Sex ratio | Overall and in each age category |
Age mid-point | Mean not median |
Age breakdown | Standardised age boundaries—age range or each year of age |
Prevalence of parasites | Defined numbers—number infected and/or percentage |
Intensity of parasites | Calculated using arithmetic not geometric mean |
Co-prevalent parasites | Named species found in a single sample |
Diagnostic used | Named method and number of replicates (slides and/or days) |
Participants treated before | Any exclusion criteria, e.g. anyone treated 1 month prior to study |
Treatment offered | Name of drug, dose, days taken. Always to be free to participant |
Location of study | GPS coordinates of site(s), or woreda name if privacy concerns dictate |
Age groups | Suggested age boundaries |
 pre-SAC | 0–4 Years of age |
 SAC | 5–14 Years of age |
 Adolescents | 14–21 Years of age |
 Adult | 22+ Years of age |